In the present study, the reduced [11C]CFT uptake reflecting the loss of integrity of the dopamine transporter was predominantly in the putamen contralateral to the clinically affected side, indicating that our PD patients in general were at an early disease stage41. This evidence concerns the gene SLC6A3 and Parkinson disease.